Ratios Reveal: Breaking Down Geron Corp. (GERN)’s Financial Health

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Geron Corp. (NASDAQ: GERN) closed the day trading at $4.17 down -3.92% from the previous closing price of $4.34. In other words, the price has decreased by -$3.92 from its previous closing price. On the day, 6.07 million shares were traded. GERN stock price reached its highest trading level at $4.37 during the session, while it also had its lowest trading level at $4.16.

Ratios:

For a better understanding of GERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.67 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.04.

On April 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $10.

Needham reiterated its Buy rating for the stock on March 15, 2024, while the target price for the stock was revised from $4 to $5.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’24 when Kapur Anil sold 421,875 shares for $4.64 per share. The transaction valued at 1,959,609 led to the insider holds 0 shares of the business.

Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 04 ’24, another insider, SCARLETT JOHN A, who serves as the Chairman, President and CEO of the company, sold 600,000 shares for $4.00 each. As a result, the insider received 2,400,000 and left with 600,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2574195456 and an Enterprise Value of 2116842752. For the stock, the TTM Price-to-Sale (P/S) ratio is 4756.45 while its Price-to-Book (P/B) ratio in mrq is 7.15. Its current Enterprise Value per Revenue stands at 4070.851 whereas that against EBITDA is -10.103.

Stock Price History:

The Beta on a monthly basis for GERN is 0.48, which has changed by 0.31545746 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is 3.28%, while the 200-Day Moving Average is calculated to be 55.83%.

Shares Statistics:

Over the past 3-months, GERN traded about 12.11M shares per day on average, while over the past 10 days, GERN traded about 11544480 shares per day. A total of 544.91M shares are outstanding, with a floating share count of 500.46M. Insiders hold about 15.62% of the company’s shares, while institutions hold 58.38% stake in the company. Shares short for GERN as of 1718323200 were 54116763 with a Short Ratio of 4.47, compared to 1715731200 on 53888364. Therefore, it implies a Short% of Shares Outstanding of 54116763 and a Short% of Float of 9.1800004.

Most Popular